STOCK TITAN

Health Catalyst';s Able Health Registry Receives CMS's QPP Qualified Registry Approval for 2024

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary
Health Catalyst, Inc. (HCAT) receives Quality Payment Program (QPP) Qualified Registry approval for 2024, enhancing its role in improving patient care and outcomes.
Positive
  • None.
Negative
  • None.

Insights

The approval of Health Catalyst's Able Health Registry by CMS as a Qualified Registry is a pivotal development for the company and its stakeholders. This designation enables Health Catalyst to play a central role in the Quality Payment Program, which is instrumental in the shift towards value-based care in the United States. Value-based care is designed to incentivize healthcare providers to offer higher quality care at lower costs, as opposed to the volume-based fee-for-service model. The Qualified Registry status implies that Health Catalyst's platform meets the stringent requirements set by CMS for reporting healthcare quality measures, which is essential for providers aiming to improve performance under the QPP's Merit-based Incentive Payment System (MIPS) and Alternative Payment Models (APMs).

For healthcare organizations, this approval means access to a CMS-recognized tool that can streamline the reporting process, potentially improving their performance scores and financial incentives. It also signifies a reduction in administrative burdens, which aligns with the program's goal to allow clinicians to focus more on patient-centered care. In the long term, this could lead to better patient outcomes and more efficient healthcare systems.

From a market perspective, Health Catalyst's recent achievement may strengthen its competitive position in the healthcare analytics and data services sector. The QPP Qualified Registry approval not only validates the company's technological capabilities but also potentially expands its customer base among healthcare providers participating in the QPP. This could translate into increased revenue streams and market share growth, as the demand for robust data reporting and analytics tools is likely to escalate with the ongoing adoption of value-based care models.

Investors and stakeholders should monitor the company's performance in upcoming quarters to assess the impact of this approval on financial results. It is also important to consider the broader industry trends, such as the growing emphasis on interoperability and predictive analytics in healthcare, which could further influence the adoption of Health Catalyst's services.

Financially, the CMS approval of Health Catalyst's registry could have a direct effect on the company's earnings and stock performance. By becoming a Qualified Registry, Health Catalyst may see an uptick in subscriptions or usage of its platform, leading to higher recurring revenue. Additionally, as healthcare providers increasingly rely on data analytics to navigate the QPP, Health Catalyst's expertise in this area could lead to partnerships or strategic alliances that enhance its financial stability and growth prospects.

It is crucial to evaluate the company's past financial performance and future guidance in light of this development. Any discrepancies between projected growth due to the CMS approval and actual performance should be scrutinized. Furthermore, stakeholders should consider the scalability of Health Catalyst's solutions and the potential for international expansion, as other countries may look to implement similar quality improvement initiatives in their healthcare systems.

SALT LAKE CITY, Feb. 21, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that the Able Health Registry has received Quality Payment Program (QPP) Qualified Registry approval for the 2024 performance year by the Centers for Medicare and Medicaid Services (CMS).

According to CMS, the QPP program "aims to improve the quality and safety of care for all individuals and to reduce the administrative burden on clinicians, allowing more time to focus on person-centered care and improving health outcomes." The Qualified Registry designation recognizes that Health Catalyst is an approved vendor to calculate and report QPP program measures.

"Registries play a powerful role in improving patient care and outcomes. This significant accomplishment reaffirms our commitment to providing healthcare organizations and agencies with the reliable tools they need to manage their registries, deliver exceptional patient care, and participate in value-based programs," said TJ Elbert, Senior Vice President, Chief Data Officer, and GM of the Technology Business Unit at Health Catalyst.

About Health Catalyst

Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage the cloud-based data platform—powered by data from more than 100 million patient records and encompassing trillions of facts—as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial, and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed.

Media Contact:

Amanda Hundt
Vice President, Corporate Communications
amanda.hundt@healthcatalyst.com
575-491-0974

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/health-catalysts-able-health-registry-receives-cmss-qpp-qualified-registry-approval-for-2024-302067057.html

SOURCE Health Catalyst

FAQ

What approval did Health Catalyst (HCAT) receive for the 2024 performance year?

Health Catalyst received Quality Payment Program (QPP) Qualified Registry approval for the 2024 performance year.

Who granted the approval to Health Catalyst (HCAT) for the 2024 performance year?

The Centers for Medicare and Medicaid Services (CMS) granted the approval to Health Catalyst (HCAT) for the 2024 performance year.

What is the aim of the QPP program according to CMS?

According to CMS, the QPP program aims to improve the quality and safety of care for all individuals and reduce the administrative burden on clinicians.

What does the Qualified Registry designation signify for Health Catalyst (HCAT)?

The Qualified Registry designation recognizes that Health Catalyst (HCAT) is an approved vendor to calculate and report QPP program measures.

Who commented on the significance of the accomplishment for Health Catalyst (HCAT)?

TJ Elbert, Senior Vice President, Chief Data Officer, and GM of the Technology Business Unit at Health Catalyst, commented on the significance of the accomplishment.

Health Catalyst, Inc

NASDAQ:HCAT

HCAT Rankings

HCAT Latest News

HCAT Stock Data

419.24M
59.25M
2.7%
90.71%
4.16%
Health Information Services
Services-computer Programming, Data Processing, Etc.
Link
United States of America
SOUTH JORDAN